In our previous GEP study involving CLL patients (n = 112) we conducted the analysis based on the IGHV mutational status and ZAP-70 (Zeta-chain-associated protein kinase 70) expression. The gene discussed is ZAP70; the disease is B-cell chronic lymphocytic leukemia.